Categories: News

HR Path Strengthens Global Presence with Strategic Acquisition of GDT Brasil

PARIS, April 16, 2026 /PRNewswire/ — HR Path, a global leader in HR consulting and HRIS solutions, is proud to announce its strategic acquisition of GDT Brasil, a management and strategy consultancy focused on improving results through human capital.

- Advertisement -

With a presence in 29 countries and a team of over 2,600 professionals, HR Path is a trusted partner for businesses navigating the complexities of Human Resources. Specializing in advisory, implementation, and operational services, HR Path delivers cutting-edge solutions designed to enhance efficiency and foster growth. Since its founding in 2001, the company has remained steadfast in its mission to transform HR practices globally. More information about HR Path: www.hr-path.com

- Advertisement -

Founded in 2003, GDT Brasil has built a strong reputation for helping organizations turn human capital into measurable business value through strategy, change management, corporate education, and people-related transformation. With a distinctive approach that connects behavior, culture, leadership, and business performance.

- Advertisement -

The company supports clients in: 

- Advertisement -
  • accelerating change adoption
  • strengthening talent retention
  • developing leaders
  • enabling sustainable transformation in complex environments

Recognized for its high-seniority delivery model, proprietary methodologies, and strong commitment to knowledge transfer, GDT Brasil empowers organizations to achieve greater agility, stronger cultures, and lasting business impact.

- Advertisement -

This acquisition represents a significant milestone for HR Path, solidifying its position as a leader in the HR industry and expanding its presence in Brazil. GDT Brasil’s specialized focus on consulting for HR and change management perfectly complements HR Path’s vision of driving organizational growth and excellence through strategic HR solutions.

- Advertisement -

“The acquisition of GDT Brasil, a company renowned for its expertise in HR consulting and change management, is a strategic move that supports our ambition to be the global reference in HR transformation,” said Ricardo, Partner and CEO at HR Path Brazil. “In 2024, Intelligenza joined HR Path with the same purpose, and now we are combining forces with GDT Brasil’s deep knowledge and strong client relationships, further complementing our global capabilities and enabling us to deliver even greater value to our clients. This partnership is not only about growth; it’s about synergy, innovation, and a shared commitment to excellence.”

- Advertisement -

PDF – https://mma.prnewswire.com/media/2956119/Release_GDT_HR_Path.pdf
Logo – https://mma.prnewswire.com/media/2956080/GDT_HR_Path_company_Logo.jpg

- Advertisement -

Contact : Fabienne LATOUR – Fabienne.latour@hr-path.com 

- Advertisement -

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/hr-path-strengthens-global-presence-with-strategic-acquisition-of-gdt-brasil-302741948.html

- Advertisement -

Recent Posts

GAC Tops Hong Kong EV Sales in April, Advancing Its High-Quality Global Expansion Strategy

HONG KONG, May 7, 2026 /PRNewswire/ -- According to the statistics on first registrations of…

16 minutes ago

Cellebrite Government Cloud Achieves FedRAMP High Authorization

Authorization at the highest security standard in the FedRAMP framework enables federal government examiners, investigators,…

16 minutes ago

SteelPower Male Enhancement Ingredient Research Gains Attention Amongst Men for Powerful Performance Support

Aurora, CO, May 06, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by…

3 hours ago

Cytokinetics Announces Pricing of Upsized Public Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today…

3 hours ago

InnoCare Announces Approval of Clinical Trial of Novel CDH7 targeted ADC ICP-B208 in China

BEIJING, May 06, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading…

3 hours ago